Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

SHSE:688505 Stock Report

Market Cap: CN¥7.5b

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 6/6

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.6B and CN¥274.5M respectively. Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd's EBIT is CN¥46.7M making its interest coverage ratio -4.3. It has cash and short-term investments of CN¥1.0B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-4.3x
CashCN¥1.04b
EquityCN¥2.35b
Total liabilitiesCN¥274.50m
Total assetsCN¥2.63b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 688505's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥265.8M).

Long Term Liabilities: 688505's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥8.7M).

Debt to Equity History and Analysis

Debt Level: 688505 is debt free.

Reducing Debt: 688505 has no debt compared to 5 years ago when its debt to equity ratio was 14.9%.

Debt Coverage: 688505 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 688505 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y